MAIA Biotechnology, Inc. MAIA IPO will take place July, 28 on the NASDAQ exchange under the ticker MAIA.
The company is offering shares at an expected price between $5.00 and $7.00 per share with an insider lock-up period of 180 days ending on January 24, 2023.
See also: Benzinga IPO Calendar
About MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO, our lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.